Paper23536610
Myocardial reperfusion injury: looking beyond primary PCI.
Fröhlich GM and 4 others. Eur Heart J, 2013. Cited by 340 papers, by iCite.
Cite this record
ConductScience Library. Myocardial reperfusion injury: looking beyond primary PCI. Papers, record 23536610. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23536610
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocardial Infarction | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| Percutaneous Coronary Intervention | Major topic |
| Animals | |
| Arrhythmias, Cardiac | |
| Atrial Natriuretic Factor | |
| Blood Glucose | |
| Calcium | |
| Cardiotonic Agents | |
| Cell Death | |
| Coronary Occlusion | |
| Disease Models, Animal | |
| Hemorrhage | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Hyperbaric Oxygenation | |
| Hypothermia, Induced | |
| Ischemic Postconditioning | |
| Microvessels | |
| Mitochondria, Heart | |
| Mitochondrial Membrane Transport Proteins | |
| Mitochondrial Permeability Transition Pore | |
| Myocardial Contraction | |
| Myocarditis | |
| Myocytes, Cardiac | |
| Nitric Oxide | |
| Oxidative Stress |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RG/08/015/26411 | British Heart Foundation | United Kingdom | PubMed | |
| FS/06/023 | British Heart Foundation | United Kingdom | PubMed |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02313961 | Remote Ischemic Conditioning in ST-elevation Myocardial Infarction as Adjuvant to Primary Angioplasty | Background | ClinicalTrials.gov | |
| NCT04912518 | Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction | Background | ClinicalTrials.gov | |
| NCT07380919 | Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study | Background | ClinicalTrials.gov |
Cited by206
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 340 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42817435 | Young Mice Exhibit Increased Relative Ventricular Remodeling After AMI-A Longitudinal CMR Study. | Aging Cell | 2026 | https://conductscience.org/library/papers/42817435 | PubMed |
| 42534919 | Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42534919 | PubMed |
| 42352000 | Cluster of Differentiation 36-Mediated Inflammation and Lipid Metabolism in Cardiovascular Diseases: From Mechanisms to Novel Therapies. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42352000 | PubMed |
| 42072458 | The Association Between Serum MOTS-c Levels and Myocardial Ischemia-Reperfusion Injury in Patients with Acute Myocardial Infarction: A Cross-Sectional Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072458 | PubMed |
| 41736666 | PAF Triggered Pyroptotic NETosis Aggravates Myocardial Ischemia/Reperfusion Injury. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41736666 | PubMed |
| 41647447 | Evaluation of the effect of trans sodium crocetinate and crocetin on reperfusion injury in acute myocardial infarction with ST-segment elevation: A double-blind, randomized, placebo-controlled clinical trial. | Avicenna J Phytomed | 2026 | https://conductscience.org/library/papers/41647447 | PubMed |
| 41604579 | Chaperone-Mediated Autophagic Degradation of USP9X in Macrophages Exacerbates Postmyocardial Infarction Inflammation and Cardiac Dysfunction. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41604579 | PubMed |
| 41440853 | The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction. | J Cardiovasc Dev Dis | 2025 | https://conductscience.org/library/papers/41440853 | PubMed |
| 41366914 | Pre-PCI SGLT2 inhibitors and contrast-induced nephropathy in acute myocardial infarction: A meta-analysis. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41366914 | PubMed |
| 41315862 | VCAM-1/Ezrin axis antagonizes myocardial damage in ischemia-reperfusion injury. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/41315862 | PubMed |
| 41309104 | The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction. | Thromb Haemost | 2026 | https://conductscience.org/library/papers/41309104 | PubMed |
| 41303012 | No-Reflow During Coronary Interventions: A Narrative Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/41303012 | PubMed |
| 41121256 | Emerging therapy strategies for energy metabolism in acute myocardial infarction. | J Transl Med | 2025 | https://conductscience.org/library/papers/41121256 | PubMed |
| 40918160 | Electroacupuncture-induced reduction of myocardial ischemia-reperfusion injury via FTO-dependent m6A methylation modulation. | Open Med (Wars) | 2025 | https://conductscience.org/library/papers/40918160 | PubMed |
| 40692417 | Breaking the Barrier: Unraveling the No-Reflow Phenomenon in Cardiovascular Medicine. | Catheter Cardiovasc Interv | 2025 | https://conductscience.org/library/papers/40692417 | PubMed |
| 40667402 | Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients. | Cardiol Res Pract | 2025 | https://conductscience.org/library/papers/40667402 | PubMed |
| 40418078 | Cardioprotective effects of the extracellular chaperone clusterin in acute myocardial infarction. | Eur J Clin Invest | 2025 | https://conductscience.org/library/papers/40418078 | PubMed |
| 40399042 | Design and synthesis of 1,4,8-triazaspiro[4.5]decan-2-one derivatives as novel mitochondrial permeability transition pore inhibitors. | J Enzyme Inhib Med Chem | 2025 | https://conductscience.org/library/papers/40399042 | PubMed |
| 40102393 | Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40102393 | PubMed |
| 40082399 | Lactylation: a promising therapeutic target in ischemia-reperfusion injury management. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40082399 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23536610
GET https://conductscience.org/api/papers/v1/23536610/cited_by?page=2